The Genetic Foundations of 21st Century Medicine
Chris Moore — Co-founder & CEO of the Nordic Group
CHRIS MOORE (DK)
CEO of the Nordic Group
Chris Moore is a health entrepreneur. His purpose in life and business is to change healthcare and empower populations to take responsibilty for their own health. He has dedicated his career to growing the field of functional medicine. He has experience in laboratory analysis, nutritional supplements and medical clinic management. Nordic Group is composed of several subsidiaries across Europe including: Nordic Laboratories, 5 Nordic Clinics, DNAlife, Nordic Health.
Chris Moore explores how 21st-century medicine can redefine health
N equals one is the single most important equation in medicine. Your genes do not dictate your life; the environment you live in coupled with your gene expression does. Understanding how you can manipulate it is enormously valuable.
Summary
- 21st-century medicine shifts focus from merely treating disease symptoms to understanding personalized health through a combination of genetics, functional tests, and longitudinal data. - The "N=1" principle is essential in healthcare, as interventions must be tailored to the individual's unique biological makeup rather than relying on broad population statistics. - Building bodily resilience requires longitudinal data, tracking how genetic structures and biochemical performance change over time in response to various environmental stressors. - Genetics do not dictate health outcomes alone; rather, understanding gene expression allows for targeted nutritional and environmental interventions to prevent the manifestation of disease. - Biohacking utilizes individualized biological data to implement health optimizations, such as using specific supplements to support impaired detoxification genes and reduce disease risk.
Article
The Genetic Foundations Of 21st Century Medicine
Chris Moore At Biohacker Summit 2023 Amsterdam Made The Case For A New Kind Of Healthcare
In Amsterdam, at Biohacker Summit 2023, Chris Moore stood before an audience already primed to question conventional medicine and pushed that skepticism further. His presentation, *The Genetic Foundations Of 21st Century Medicine*, was not a plea for gadgetry or self-obsession. It was an argument for a profound shift in how health itself is understood: away from reactive medicine, away from waiting for disease to announce itself, and toward a model built on prediction, personalization, and participation.
Moore, CEO of the Nordic Group and a long-time health entrepreneur, framed the future of medicine as intensely individual. “It doesn't matter what everybody else is doing,” he said. “It is a question of what is right for you.”
That sentence carried the force of a manifesto. In Moore’s telling, the great failing of 20th-century medicine had lingered into the 21st: a system remarkably skilled at naming disease, but far less fluent in defining health. The tools now existed, he argued, to correct that imbalance through genetics, functional testing, longitudinal data, and behavior change.
From Population Averages To The Power Of N Equals One
At the heart of Moore’s talk was a deceptively simple equation: N = 1.
For him, it was “the single most important equation in medicine.” A treatment that benefits 99 percent of people means very little, he suggested, if you happen to belong to the 1 percent harmed by it. The age of generalized advice, broad averages, and one-size-fits-all protocols was giving way to something more precise and, in many ways, more demanding.
Personalized healthcare, in Moore’s framework, required not just a genetic snapshot but repeated measurements over time. He described this as the creation of “longitudinal knowledge,” a living record of how a body responds to stress, sleep, food, supplements, exercise, heat, cold, and the invisible pressures of modern life.
“Data is power,” Moore said. “It is not just about the raw data; it is about the knowledge, the utilization, and the implementation. It is no good knowing about your genes and doing nothing; you have to test your hypothesis and take action.”
This was biohacking recast not as vanity, but as disciplined self-observation.
The Nordic Biohacker Experiment And The Search For Biological Resilience
Moore used his presentation to spotlight the Nordic Biohacker Experiment, an ongoing project comparing self-selecting biohackers with the general population. It was not presented as a clinical trial, but as a social and biological learning exercise, an attempt to understand whether the people most obsessed with performance also carried distinctive patterns of genetic risk.
What emerged, according to Moore, was a portrait of contradiction.
One gene variant, COMT AA, appeared more frequently among biohackers than might be expected and was associated with greater anxiety and mood-related vulnerability. Yet another pattern in the same gene, tied to neurodegenerative risk, appeared less prevalent in this group than in the broader population. The implication was striking: the people most worried about their health might, in some cases, be biologically predisposed to that worry, but also more motivated to intervene early.
Moore’s reading of this was less pathological than pragmatic. Anxiety, in this context, had become action. Genetic risk had become a prompt for self-experimentation.
He also pointed to TNF-alpha variants linked to fatigue, inflammation, insulin resistance, and lipid problems, arguing that these risks could be moderated with targeted support, including omega fatty acids, curcumin, ginger, resveratrol, and anthocyanins. In cases involving impaired detoxification genes such as GSTM1 and GSTT1 deletions, he suggested compounds like sulforaphane could help support protective pathways.
The message was consistent throughout: genes were not destiny. They were early warnings.
Genes Load The Gun, Environment Pulls The Trigger
Moore returned repeatedly to a familiar line in personalized medicine: genes load the gun, environment pulls the trigger.
It is a phrase that can sound glib in less careful hands. In Amsterdam, he used it to make a more nuanced point. Genetic information mattered not because it predicted a fixed future, but because it revealed where intervention might matter most. If a person understood where vulnerability lay, then nutrition, lifestyle, supplementation, and monitoring could become tools of prevention rather than desperate acts of repair.
“If we work early enough on the phenotype, we prevent disease from developing,” Moore said. “It is really that simple: find out where the risk is and make the necessary changes to your environment and nutrition to protect your future.”
Phenotype, in his vocabulary, was where genes met real life: gut function, metabolic efficiency, inflammatory burden, energy production, cognitive performance. A genetic test might suggest a weakness. Functional testing, he argued, could show whether that weakness had already begun to express itself.
This was the conceptual bridge between inherited code and lived experience.
The Body As A Continuous Dataset
There was also, inevitably, technology.
Moore described implantable and wearable tools, including an NFC-powered thermometer, as part of a wider effort to turn the body into a measurable system. His examples ranged from monitoring temperature shifts during sauna and cold-water immersion to gathering data that might help women better understand ovulation and menstrual timing.
The point was not merely novelty. It was iteration. How did a sauna session affect sleep? Did cold exposure improve resilience or simply add stress? Was a protocol helping energy, mood, or recovery over time, or just offering the illusion of control?
These questions, once left to instinct or anecdote, were now being tested through self-tracking. Moore also referenced his own use of hyperbaric therapy, ozone, and laser treatments as part of a broader optimization regimen, though always under the larger philosophy that health gains come from combinations of interventions, not single miracles.
Nutrition, sleep, movement, mindfulness, lab testing, and environmental exposures all had to be understood together. Medicine, in this telling, was becoming systems biology with a personal dashboard.
Pregnancy, Prevention, And The Most Persuasive Statistic Of The Day
The most arresting part of Moore’s presentation came not from adult performance enhancement but from prenatal care.
He cited the Grow Baby study in the United States, in which genetic-informed nutritional support for pregnant women was associated with a dramatic reduction in preterm birth rates, from 11 percent in the general population to 1.5 percent in the intervention group. The significance of that claim reached beyond biohacking culture and into public health itself.
If supported at scale, such findings would challenge the idea that genetics belongs only in elite wellness circles. It would suggest, instead, that personalized intervention could begin before birth and shape outcomes at the very start of life.
Moore’s point was both commercial and moral. If he were “starting the journey again,” he said, he would want his parents to have had access to this information. The future of healthcare, as he presented it, was not simply about extending lifespan for the already health-literate. It was about reducing risk before damage took hold.
A Community, Not Just A Consumer Market
There was, too, a social vision running beneath the technical claims.
Moore urged the audience not to pursue optimization in isolation but as part of a learning community. Through webinars, shared experiences, and group interpretation of results, he suggested, biohackers could become collaborators in a distributed experiment on human performance.
“The journey towards optimization is a long one, but it doesn't have to be a lonely one,” he said. “The more we learn and the more we share, the better we are. We must encourage each other to be better humans and better performers.”
That language revealed something important about the appeal of events like Biohacker Summit 2023 Amsterdam. They are not merely marketplaces for supplements, sensors, and speculative therapies. They are gatherings built on a powerful modern instinct: the suspicion that institutions have moved too slowly, and that individuals, armed with enough data, might get there first.
The Promise And The Tension Of Personalized Medicine
Moore’s presentation was ambitious, persuasive, and deeply aligned with the sensibility of his audience. It offered a future in which disease might be anticipated, gene expression modulated, and chronic decline postponed through informed action. It treated curiosity as a clinical asset and self-knowledge as a health intervention.
Yet what made the talk compelling was also what made it provocative. Personalized medicine, as Moore described it, placed new responsibility on the individual. The burden was no longer simply to seek treatment when sick, but to gather data, interpret risk, monitor change, and intervene constantly. Empowerment and obligation began to blur.
Still, Moore’s closing sentiment captured the mood in the room and, perhaps, the wider movement gathering around this kind of medicine.
“Biohackers are the future,” he said. “You are the way we are going to change things by understanding how we perform. Embrace that knowledge, use it to build resilience against disease, and change how you live your life.”
In Amsterdam, that did not sound like fringe rhetoric. It sounded, for many listening, like an early draft of the medical century to come.
Part of Biohacker Summit 2023 Amsterdam